Driven by biotechnological innovation, the company focuses on pharmaceutical R&D, production service outsourcing and microecological medicine. The company provides integrated services for large and medium-sized pharmaceutical companies, biotechnology companies, research institutes, etc. around the world, covering everything from early drug discovery to drug development and large-scale production stages, and standardization, precision, and human microecological health management of microecological medicine. Committed to becoming the world's leading CRO&CDMO partner and a full-life cycle integrated solution service provider for global pharmaceutical innovation. The company provides drug discovery, development and production services to global pharmaceutical companies, biotechnology companies and research institutes. The company's main products and services include computer-aided drug design, synthetic compound library design, medicinal chemistry, peptide chemistry, fragment-based drug screening, analytical chemistry support and development, early process development, process safety assessment, milligram to kg amplification synthesis, pharmacological efficacy, pharmacological pharmacokinetics, biopharmaceutical R&D services, biopharmaceutical development and production, etc. Corporate honors: Won the “Top Ten Drug Innovation Service Agencies of the Year”, won the “2022 Top 20 Most Influential CXO Companies”, ranked in the “2021 Best Preclinical CRO/CDMO Companies” list, Shanghai Wisdom was selected as a TOP10 CRO company in the “2020 China Pharmaceutical Industry Top 100 Series List” for three consecutive years, and was awarded China's Top 10 Innovative CRO Companies, etc.